Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Confusion on warrant expiry date
View:
Post by aussyspitz on May 12, 2022 8:59pm

Confusion on warrant expiry date

Every thing I am reading shows expiry date of August 22, 2024 https://cassels.com/rep_work/theralase-completes-17-25-million-prospectus-offering/ am I missing something
Comment by menoalittle on May 13, 2022 9:38am
you're looking at different warrants.
Comment by Legit62 on May 13, 2022 9:41am
I think he is referring to stock being at high price so warrants had some value then cause u could buy at .30
Comment by Pandora on May 13, 2022 11:21am
1) Warrants issued with completed financing of January 2019: Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $0.50 per share for a period of 24 months following the date of issuance. (i.e. January 9, 2019) Please note news issued on January 8, 2021: The Warrants were issued on January 9, 2019 pursuant to a private placement involving the issuance ...more  
Comment by Pandora on May 13, 2022 12:04pm
My apologies for a couple of typos in that note (brain freezes at times) In item 1) the date in brackets should say (i.e. January 9, 2021) In item 4) the date in the statement Please note news issued May 11, 2014: should say May 11, 2020
Comment by Legit62 on May 13, 2022 12:13pm
I dont think warrants can be extended twice, so i believe you are correct, the question is, do we know how many warrants remain and how many will expire tomorrow?
Comment by Pandora on May 13, 2022 12:37pm
an aggregate of 5,104,000 Units i.e. including 5,104,000 warrants were issued. The exercise price on the warrants is 30 cents. From December 2021 through April of this year the share price has managed to maintain a price slightly above the 30 cent level so presumably people may have been motivated to exercise the warrants. No idea where or who keeps count.
Comment by Infinity on May 13, 2022 1:20pm
Pandora, If I were holding warrants, I would wait till the last week before expiry. Simply I am guaranteed the purchase price at $.30. No need to block up my money that I can use elsewhere for better gain. Best of all mininise any risk. At this price, It makes sense to just by the shares instead..
Comment by Legit62 on May 13, 2022 1:37pm
I would totally agree with you Infinity, no need to exercise early
Comment by Legit62 on May 13, 2022 1:46pm
On the run up in price we had recently, i would bet alot of those warrants were exercised due to holders feeling we were heading up to dollar figures and not looking back, IMO
Comment by Legit62 on May 13, 2022 1:50pm
The timing of exercising the other outstanding warrants will get a little dicey in fall because if they miss out on the warrant price , they will miss the BIG run up once we get BTD and commercialization
Comment by Rumpl3StiltSkin on May 13, 2022 2:24pm
I actually think they, 50c warrants, have a good chance of exercising. With improving numbers, we could see a JV announced. Or perhaps the Animal data on the Covid Vax front will come out solid. Either of those could happen between now and Oct.
Comment by Pandora on May 13, 2022 1:41pm
I agree with you infinity. I did not/do not hold any of these aforementioned warrants. I held the 37.5 cent warrants for 5 years which expired on Nov. 21, 2021 and were never extended - so they're just gone.
Comment by CAinPlap on May 13, 2022 2:12pm
I may be one of the few outside management that have the Oct 3 2022 .50 warrants. I remember being dissapointed in the lack of funds raised in that round of financing.
Comment by Lesalpes29 on May 13, 2022 12:53pm
Shares count could be an indicator. But simply ask to the company. Of course IR is not hired yet.
Comment by Rumpl3StiltSkin on May 13, 2022 1:04pm
I think Share/warrant/option count should be ~ 280Million after these expire EoD...
Comment by Oilminerdeluxe on May 13, 2022 1:12pm
Not sure if it is important or not, but I know there was talk on the board way back that warrants could not be extended again. If that is true or not, I do not know, but I know that subject was talked about.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250